documents: CDC-2020-0046-0141
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CDC-2020-0046-0141 | CDC | CDC-2020-0046 | Request for Public Comment on NIOSH Initial Recommendations To Change the Status of Liraglutide and Pertuzumab on the NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings | Notice | 2024-01-16T05:00:00Z | 2024 | 1 | 2024-01-16T05:00:00Z | 2024-02-16T04:59:59Z | 2024-02-16T02:00:32Z | 2024-00693 | 0 | 0 | 090000648639cec4 |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref